NCT01977638View on ClinicalTrials.gov

Phase 1 Trial of CXD101 in Patients With Advanced Cancer

PHASE1CompletedINTERVENTIONAL

Enrollment

51

Participants

Timeline

Start Date

February 14, 2014

Primary Completion Date

October 8, 2019

Study Completion Date

October 14, 2022

Conditions

Advanced Cancer

Interventions

DRUG

CXD101

Capsules, administered orally

Trial Locations (1)

OX3 7LE

Oxford University Hospitals NHS Trust, Oxford

Sponsors

Collaborators (1)

Cancer Research UK

All Listed Sponsors

collaborator

University of Oxford

OTHER

collaborator

National Institute for Health Research, United Kingdom

OTHER_GOV

collaborator

Cancer Research UK

OTHER

lead

Oxford University Hospitals NHS Trust

OTHER

NCT01977638 - Phase 1 Trial of CXD101 in Patients With Advanced Cancer | Biotech Hunter | Biotech Hunter